欧盟 - 英文 - EMA (European Medicines Agency)

lipomed gmbh - cladribine - leukemia, hairy cell - antineoplastic agents - litak is indicated for the treatment of hairy-cell leukaemia.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eculizumab 300mg;  ;  ;   - solution for infusion - 300mg/30ml - active: eculizumab 300mg       excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - soliris® is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria (pnh)to reduce haemolysis.

美国 - 英文 - NLM (National Library of Medicine)

harmony biosciences, llc - pitolisant hydrochloride (unii: yv33ch63hi) (pitolisant - unii:4bc83l4piy) - wakix is indicated for the treatment of excessive daytime sleepiness (eds) or cataplexy in adult patients with narcolepsy. wakix is contraindicated in patients with: - known hypersensitivity to pitolisant or any component of the formulation. anaphylaxis has been reported in patients treated with wakix [see adverse reactions (6.2)] . - severe hepatic impairment. wakix is extensively metabolized by the liver and there is a significant increase in wakix exposure in patients with moderate hepatic impairment [see use in specific populations (8.6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women who are exposed to wakix during pregnancy. patients should be encouraged to enroll in the wakix pregnancy registry if they become pregnant. to enroll or obtain information from the registry, patients can call 1-800-833-7460. risk summary available case reports from clinical trials and postmarketing reports with wakix use in pregnant women have not determined a d

以色列 - 英文 - Ministry of Health

roche pharmaceuticals (israel) ltd - polatuzumab vedotin - powder for concentrate for solution for infusion - polatuzumab vedotin 140 mg/vial - polivy in combination with bendamustine and rituximab is indicated for the treatment of previously treated adult patients with diffuse large b-cell lymphoma who are not candidates for hematopoietic stem cell transplant.polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - escherichia coli k88ac pilus antigens; escherichia coli 987p pilus antigens; escherichia coli k99 pilus antigens; escherichia coli k88ab pilus antigens; formaldehyde solution; thiomersal - misc. vaccines or anti sera - escherichia coli k88ac pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli 987p pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli k99 pilus antigens vaccine-microbial active 12.5 ug/ml; escherichia coli k88ab pilus antigens vaccine-microbial active 12.5 ug/ml; formaldehyde solution aldehyde other 2.5 ug/ml; thiomersal mercury other 0.15 mg/ml - immunotherapy - pig - piglet | neonatal piglet | new born pig | sucker pig - escherichia coli (e. coli) | scours - neonatal | vaccine | equine rotavirus | including b-lactamase producin

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

fair-med healthcare gmbh - valsartan hydrochlorothiazide - film coated tablet - 160/12.5 mg/mg

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

fair-med healthcare gmbh - valsartan hydrochlorothiazide - film coated tablet - 160/25 mg/mg

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

fair-med healthcare gmbh - valsartan hydrochlorothiazide - film coated tablet - 80/12.5 mg/mg

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

fair-med healthcare gmbh - valsartan hydrochlorothiazide - film coated tablet - 320/12.5 mg/mg

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

fair-med healthcare gmbh - valsartan hydrochlorothiazide - film coated tablet - 320/25 mg/mg